RNA interference: A potent tool for gene-specific therapeutics

被引:78
作者
Ichim, TE
Li, M
Qian, H
Popov, IA
Rycerz, K
Zheng, XF
White, D
Zhong, R
Min, WP [1 ]
机构
[1] Univ Western Ontario, Dept Surg Microbiol & Immunol, London, ON, Canada
[2] London Hlth Sci Ctr, Multiorgan Transplant Program, London, ON, Canada
[3] Lawson Hlth Res Inst, London, ON, Canada
[4] Robarts Res Inst, London, ON N6A 5C1, Canada
关键词
gene silencing; gene therapy; RNA interference; transplantation;
D O I
10.1111/j.1600-6143.2004.00530.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
RNA interference (RNAi) is a process through which double-stranded RNA induces the activation of cellular pathways, leading to potent and selective silencing of genes with homology to the double strand. Much excitement surrounding small interfering RNA (siRNA) mediated therapeutics arises from the fact that this approach overcomes many of the shortcomings previously experienced with approaches such as antibodies, antisense oligonucleotides and pharmacological inhibitors. Induction of RNAi through administration of siRNA has been successfully used in treatment of hepatitis, viral infections, and cancer. In this review we will present a brief history of RNAi, methods of inducing RNAi, application of RNAi in the therapeutic setting, and the possibilities of using this highly promising approach in the context of transplantation.
引用
收藏
页码:1227 / 1236
页数:10
相关论文
共 104 条
[1]   Lentiviral-mediated RNA interference [J].
Abbas-Terki, T ;
Blanco-Bose, W ;
Déglon, N ;
Pralong, W ;
Aebischer, P .
HUMAN GENE THERAPY, 2002, 13 (18) :2197-2201
[2]   RNA interference: Biology, mechanism, and applications [J].
Agrawal, N ;
Dasaradhi, PVN ;
Mohmmed, A ;
Malhotra, P ;
Bhatnagar, RK ;
Mukherjee, SK .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 2003, 67 (04) :657-+
[3]   Escherichia coli ribonuclease III:: Affinity purification of hexahistidine-tagged enzyme and assays for substrate binding and cleavage [J].
Amarasinghe, AK ;
Calin-Jageman, I ;
Harmouch, A ;
Sun, WM ;
Nicholson, AW .
RIBONUCLEASES, PT B, 2001, 342 :143-158
[4]   Addition of a water-soluble α-tocopherol analogue to university of Wisconsin solution improves endothelial viability and decreases lung reperfusion injury [J].
Baker, CJ ;
Longoria, J ;
Gade, PV ;
Starnes, VA ;
Barr, ML .
JOURNAL OF SURGICAL RESEARCH, 1999, 86 (01) :145-149
[5]   Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in T lymphocytes differentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages [J].
Banerjea, A ;
Li, MJ ;
Bauer, G ;
Remling, L ;
Lee, NS ;
Rossi, J ;
Akkina, R .
MOLECULAR THERAPY, 2003, 8 (01) :62-71
[6]   Retroviral delivery of small interfering RNA into primary cells [J].
Barton, GM ;
Medzhitov, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (23) :14943-14945
[7]   Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo [J].
Bertrand, JR ;
Pottier, M ;
Vekris, A ;
Opolon, P ;
Maksimenko, A ;
Malvy, C .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 296 (04) :1000-1004
[8]  
Billaud EM, 2000, THERAPIE, V55, P177
[9]   Immunobiology of allograft rejection in the absence of IFN-γ:: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions [J].
Bishop, DK ;
Wood, SC ;
Eichwald, EJ ;
Orosz, CG .
JOURNAL OF IMMUNOLOGY, 2001, 166 (05) :3248-3255
[10]   Induction of an interferon response by RNAi vectors in mammalian cells [J].
Bridge, AJ ;
Pebernard, S ;
Ducraux, A ;
Nicoulaz, AL ;
Iggo, R .
NATURE GENETICS, 2003, 34 (03) :263-264